i3 Health's surveys of oncology nurses at the Oncology Nursing Society (ONS) 44th Annual Congress in Anaheim, California, in April 2019 revealed respondents' preferred formats for continuing nursing education (CNE) activities.
The surveys focused on educational needs concerning immune checkpoint inhibitors, cyclin-dependent kinase (CDK)4/6 inhibitors, chimeric antigen receptor (CAR) T-cell therapy, poly (ADP)-ribose polymerase (PARP) inhibitors, and biosimilars. Surveys were completed by 304 oncology nurses, including 107 inpatient nurses (35.2%), 67 clinic nurses (22.0%), 59 infusion nurses (19.4%), 31 nurse educators (10.2%), 18 nurse practitioners (5.9%), 17 clinical nurse specialists (5.6%), 16 nurse managers and supervisors (5.3%), 15 nurse navigators (4.9%), 13 research nurses (4.3%), 10 triage nurses (3.3%), 6 administrators (2.0%), and 2 nurses involved in quality control or patient safety (0.6%).
Oncology nurses showed the greatest preference for CNE activities that took place at local meetings, such as those held by hospitals or ONS chapters; these were chosen by 53.0% of respondents. The second most popular format was live online activities, such as webcasts and webinars (37.5%). Other preferred formats included mobile apps (28.9%); national conferences (24.3%); enduring online activities, such as monographs, videos, and podcasts (23.3%); print materials (21.7%); and regional conferences (20.4%).
Many of the nurses surveyed expressed an interest in technology-based learning such as the online activities provided by i3 Health, an American Council for Continuing Medical Education (ACCME)- and American Nurses Credentialing Center (ANCC)-accredited provider of CNE and continuing medical education (CME).